Collaborative care program for young adults with Type 1 Diabetes and emotional distress
Official title: Technology-Enabled Collaborative Care for Young Adults With Type-1 Diabetes and Diabetes Distress (TECCT1D3): Feasibility Trial of a Co-designed Intervention
Run by Centre for Addiction and Mental Health · NCT06804694 · Data updated 2026-11-12
This study is testing a new program to see if coaching or education helps young adults with Type 1 Diabetes manage their diabetes and emotional distress better.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 29 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Centre for Addiction and Mental Health Academic / other |
| Locations | 1 site (Toronto, Ontario) |
| Status | Recruiting |
| Started | November 27, 2024 |
| Main results expected | September 2025 |
| Study ends | September 2025 |
| Registry record updated | February 3, 2025 |
| Trial ID | NCT06804694 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are young adults aged 18-29 living in Ontario with a self-reported diagnosis of Type 1 Diabetes for at least one year.
✕Probably not a fit
Patients who are unable to participate in English or those who cannot engage via telephone or web-conferencing may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the feasibility and acceptability of a co-designed program called Technology-Enabled Collaborative Care for Young Adults with Type 1 Diabetes and Diabetes Distress (TECC-T1D3). It involves enrolling 60 young adults who will be randomly assigned to either a coaching intervention or an education intervention over a 12-week period. The coaching group will engage in sessions with a health coach to discuss diabetes management and emotional wellbeing, while the education group will receive automated educational content. Surveys and interviews will be conducted to assess the impact of the interventions on participants' experiences and management of diabetes-related distress.
Why it matters
Potential benefit: If successful, this program could significantly improve the quality of life for young adults with Type 1 Diabetes by addressing both their physical and mental health needs.
How similar studies have gone: While the integration of mental health support with diabetes management is a growing area of interest, this specific approach is relatively novel and has not been extensively tested in similar studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Young adult (age 18-29 years) * Resident of Ontario * Living with a self-reported diagnosis of T1D of at least 1 year * Individual is community-living (people who live independently in the community and are not residing in a setting that provide institutional care or support) Exclusion Criteria: * Unable to participate in English language * Unable to participate via telephone or web-conferencing
Where it's running
-
Centre for Addiction and Mental Health
Toronto, Ontario, Canada Recruiting
Study contacts
- Principal investigator: Peter Selby — Centre for Addiction and Mental Health
- Study coordinator: Anika Saiva, MPH
- Email: anika.saiva@camh.ca
- Phone: (416) 535-8501
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Benefits of Retained Insulin for Good Health in Diabetes
This study tests whether preserving or restoring a person’s own insulin production can improve quality of life and blood sugar control for people who need insulin to manage diabetes.
-
Predictive CGM with App for people with type 1 or insulin-treated type 2 diabetes
This study tests whether using the Accu-Chek SmartGuide CGM with its Predict App can reduce fear of hypoglycemia and improve related behaviors and confidence in adults with type 1 or insulin-treated type 2 diabetes.
-
Intermittent CGM Use in high-risk children and teens with Type 1 Diabetes in the Dominican Republic
This study tests whether using the Dexcom G7 intermittently, along with pediatric care and support, can improve glucose control in 10–19 year-olds with high-risk Type 1 Diabetes in the Dominican Republic.
-
AI-assisted remote insulin pump optimization for people with type 1 diabetes
This study tests an AI-powered tool that suggests insulin pump settings for people with type 1 diabetes, with doctor-approved recommendations delivered to a mobile app.
-
GlycoQuest: an AI-powered CGM game for kids with type 1 diabetes and their families
A CGM-linked, AI-adaptive serious game is tested with children 6-17 who have type 1 diabetes and their primary caregivers to see if it helps with glucose control and coping in the first year after diagnosis.
-
AMX0035 in adults with Type 1 Diabetes
This study tests whether 24 weeks of the oral medication AMX0035 help improves metabolic health in adults with Type 1 Diabetes compared with a placebo.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.